The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 1, 1998, Pages 85-92

  Sinisalo, Juha ^a   Mattila, Kimmo ^a   Nieminen, Markku S ^a   Valtonen, Ville ^a   Syrjälä, Martti ^a   Sundberg, Stig ^b   Saikku, Pekka ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ORION CORPORATION   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DOXYCYCLINE; FIBRINOGEN; NITRIC OXIDE; TRIACYLGLYCEROL;

ADULT; ANTIBIOTIC THERAPY; ARM BLOOD FLOW; ARTICLE; BORDERLINE HYPERTENSION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DOUBLE BLIND PROCEDURE; FIBRINOGEN BLOOD LEVEL; FOREARM; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LABORATORY TEST; MALE; ORAL DRUG ADMINISTRATION; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; RASH; RISK FACTOR; SEROLOGY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031882967     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.1.85     Document Type: Article

References (44)

1. Mlot, C. (1996). Chlamydia linked to atherosclerosis. Science 272, 1422.
2. Saikku, P., Leinonen, M., Mattila, K., Ekman, M. R., Nieminen, M. S., Mákelá, P. H., et al. (1988). Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet iii, 983-6.
3. Linnanmáki, E., Leinonen, M., Mattila, K., Nieminen, M. S., Valtonen, V. & Saikku, P. (1993). Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 87, 1130-4.
4. Saikku, P., Leinonen, M., Tenkanen, L., Linnanmáki, E., Ekman, M.-R., Manninen, V. et al. (1992). Chronic Chlamydia pneumoniae infection as risk factor for coronary heart disease in the Helsinki heart study. Annals of Internal Medicine 116, 273-8.
5. Thom, D. H., Wang, S. P., Grayston, J. T., Siscovick, D. S., Stewart, D. K., Kronmal, R. A. et al. (1991). Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arteriosclerosis and Thrombosis 11, 547-51.
6. Kuo, C. C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L. & Grayston, J. T. (1993). Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. Journal of Infectious Diseases 167, 841-9.
7. Campbell, L. A., O'Brian, E. R., Cappuccio, A. L., Kuo, C. C., Wang, S. P., Stewart, D. et al. (1995). Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. Journal of Infectious Diseases 172, 585-8.
8. Ong, G., Thomas, B. J., Mansfield, A. O., Davidson, B. R. & Taylor-Robinson, D. (1996). Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. Journal of Clinical Pathology 49, 102-6.
9. Kauppinen, M. & Saikku, P. (1995). Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clinical Infectious Diseases 21, Suppl. 3, 5244-52.
10. Lauhio, A., Leirisalo-Repo, M., Láhdevirta, J., Saikku, P. & Repo, H. (1991). Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis and Rheumatism 34, 6-14.
11. Sammalkorpi, K., Valtonen, V., Kerttula, Y., Nikkilá, E. & Taskinen, M. R. (1988). Changes in serum lipoprotein pattern induced by acute infections. Metabolism 37, 859-65.
12. Leinonen, M. (1993). Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. European Heart Journal 14, Suppl. K, 57-61.
13. Williams, D. M., Magee, D. M., Bonewald, L. F., Smith, J. G., Bleickar, C. A., Byrne, G. I. et al. (1990). A role in vivo for tumor necrosis factor alpha in host defence against Chlamydia trachomatis. Infections and Immunology 58, 1572-6.
14. Kaukoranta-Tolvanen, S. S., Teppo, A. M., Leinonen, M., Saikku, P. & Laitinen, K. (1992). Chlamydia pneumoniae induces the production of TNFα, IL-1β and IL-6 by human monocytes. Proceedings of European Society of Chlamydia Research 2, 85.
15. Kawakami, M., Pekala, P. H., Lane, M. D. & Cerami, A. (1982). Lipoprotein lipase supression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proceedings of the National Academy of Sciences of the USA 79, 912-6.
16. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-9.
17. Shimokawa, H. & Takeshita, A. (1995). Endothelium-dependent regulation of the cardiovascular system. Internal Medicine 34, 939-46.
18. Föstermann, U., Pollock, J. S. & Nakane, M. (1993). Nitric oxide synthases in the cardiovascular system. Trends in Cardiovascular Medicine 3, 104-10.
19. Busse, R. & Mulsch, A. (1990). Induction of nitric oxide sythase by cytokines in vascular smooth muscle cells. FEBS Letters 275, 87-90.
20. Nava, E., Palmer, R. M. J. & Moncada, S. (1991). Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338, 1555-7.
21. Stuart, J., George, A. J., Davies, A. J., Aukland, A. & Hurlow, R. A. (1981). Haematological stress syndrome in atherosclerosis Journal of Clinical Pathology 34, 464-7.
22. Cortellaro, M., Boschetti, C., Colfranesco, E., Zanussi, C., Catalano, M., de Gaetano, G. et al. (1992). The PLAT study: haemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: principal results. Arteriosclerosis and Thrombosis 12, 1063-70.
23. Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F. & van de Loo, J. C. W. (1995). Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New England Journal of Medicine 332, 635-41.
24. Meade, T. W., Mellows, S., Brozovic, M., Miller, G. J., Chakrabarti, R. R., North, W. R. et al. (1986). Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart study. Lancet ii, 533-7.
25. Wilhelmsen, L., Svárdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L. & Tibblin, G. (1984). Fibrinogen as a risk factor for stroke and myocardial infarction. New England Journal of Medicine 311, 501-5.
26. Stone, M. C. & Thorp, J. M. (1985). Plasma fibrinogen: a major coronary risk factor. Journal of the Royal College of General Practitioners 35, 565-9.
27. Heinrich, J., Balleisen, L., Schulte, H., Assman, G. & van de Loo, J. (1994). Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men Arteriosclerosis and Thrombosis 14, 54-9 and 1392 (correction).
28. Cremer, P., Nagel, D., Labrot, B., Mann, H., Muche, R., Elster, H. et al. (1994). Lipoprotein Lp(a) as a predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study. European Journal of Clinical Investigation 24, 444-53.
29. Handa, K., Kono, S., Saku, K., Sasaki, J., Kawano, T. Sasiki Y. et al. (1989). Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis 77, 209-13.
30. Yarnell, J. W. G., Baker, I. A., Sweetnam, P. M. Bainton, D., O'Brien, J. R., Whitehead, P. J. et al. (1991). Fibrinogen viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83, 836-44.
31. Heinrich, J., Schulte, H., Schönfeld, R., Köhler, E. & Assmann, G. (1995). Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thrombosis and Haemostatis 73, 374-9.
32. Sundberg, S. (1995). Variation in plethysmographically measured limb blood flow using two study designs. Clinical Physiology 15, 199-206.
33. Whitney, R. J. (1953). The measurement of volume changes in human limbs. Journal of Physiology (London) 121, 1-27.
34. Kerslake, D. M. (1949). The effect of the application of an arterial occlusion cuff to wrist on the blood flow in the human forearm. Journal of Physiology (London) 108, 451-7.
35. Webb, D. J. (1995). The pharmacology of human blood vessels in vivo. Journal of Vascular Research 32, 2-15.
36. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 18, 499-502.
37. Wang, S. P. & Grayston, J. T. (1970). Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in new microtiter indirect immunofluorescence test American Journal of Ophthalmology 70, 367-74
38. Farrell, W. & Williams, J. D. (1978). Tetracyclines. In Laboratory Methods in Antimicrobial Chemotherapy (Reeves, D. S., Phillips, I., Williams, D. J. & Wise, R., Eds), pp. 237-8. Churchill Livingstone, Edinburgh.
39. Puolakkainen, M., Kuo, C.-C., Shor, A., Wang, S.-P., Grayston, J. T. & Campbell, L. A. (1993). Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. Journal of Clinical Microbiology 31, 2212-4.
40. Grayston, J. T., Campbell, L. A., Kuo, C. C., Mordhorst, C. H., Saikku, P., Thom, D. H. et al. (1990). A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. Journal of Infectious Diseases 161, 618-25.
41. Dahlén, G. H., Boman, J., Birgander, L. S. & Lindblom, B. (1995). Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 114, 165-74.
42. Vane, J. R., Anggard, E. E. & Botting, R. M. (1990). Regulatory functions of vascular endothelium. New England Journal of Medicine 323, 27-36.
43. Liuzzo, G., Biasucci, L. M., Rebuzzi, A. G., Gallimore, J. R., Caligiuri, G., Lanza, G. A. et al. (1996). Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 94, 2373-80.
44. Haverkate, F., Thompson, S. G., Pyke, S. D. M., Gallimore, J. R. & Pepys, M. B. (1997). Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349, 462-6.